The Directorate General Of Foreign Trade (DGFT) on May 23, 2022 has issued a notification to amend certain items under schedule I of the import policy under chapter 29 and 30 of (HS) 2022.
The import policy of the following items have been changed:
• Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones.
• Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues : -- Other
• Steroidal hormones, their derivatives and structural analogues : -- Other
• Catecholamine hormones, their derivatives and structural analogues: ---- Other
• Other
• Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale.
The Import of Oxytocin is Prohibited. However, import of Oxytocin reference standards is allowed exclusively for test and analysis subject to submission of Test License for all of the above items.
Import of Oxytocin shall remain "Prohibited". However, import of Oxytocin reference standards falling under HS Codes 29371900, 29372900, 29379019, 29379090 and all HS Codes at 8 digit level under 3004 is permitted exclusively for the purpose of test and analysis subject to submission of Test License issued by the DGCI / CDCSO.
[Notification No. 09 /2015-2020]
